Site search
2909 results for '' found
An immune-therapeutic salvage strategy for ‘functional’ high-risk (FHR) multiple myeloma incorporating Iberdomide, Isatuximab, and Dexamethasone (Iber-IsaDex) – the IBIS study (ACTRN1262100103789
An immune-therapeutic salvage strategy for ‘functional’ high-risk (FHR) multiple myeloma incorporating Iberdomide, Isatuximab, and Dexamethasone (Iber-IsaDex) – the IBIS study (ACTRN1262100103789
/
HOME-AKI: Haemofiltration with Oxiris: Multicentre Evaluation in Acute Kidney Injury (U1111-1247-3435)
HOME-AKI: Haemofiltration with Oxiris: Multicentre Evaluation in Acute Kidney Injury (U1111-1247-3435)
/
A phase 3, multicenter, open-label, randomized, study of gilteritinib versus midostaurin in combination with induction and consolidation therapy followed by one year maintenance in patients with
A phase 3, multicenter, open-label, randomized, study of gilteritinib versus midostaurin in combination with induction and consolidation therapy followed by one year maintenance in patients with
/
Home-based Minimal Equipment Exercise Training (H-MEET) delivered using remote supervision: A randomised controlled feasibility study (ACTRN12625000550404)
Home-based Minimal Equipment Exercise Training (H-MEET) delivered using remote supervision: A randomised controlled feasibility study (ACTRN12625000550404)
/
Expanded study of the HighLife™ 28mmtranscatheter trans-septal mitral valve in patients with moderatesevere or severe mitral regurgitation and at high surgical risk (NCT04029363)
Expanded study of the HighLife™ 28mmtranscatheter trans-septal mitral valve in patients with moderatesevere or severe mitral regurgitation and at high surgical risk (NCT04029363)
/
Use of the Hexoskin shirt for assessment of patients with dysfunctional breathing compared to healthy controls (Trial Not Registered)
Use of the Hexoskin shirt for assessment of patients with dysfunctional breathing compared to healthy controls (Trial Not Registered)
/
Hearts and Minds: A 3-arm Multicentre, Randomised, Double-Blind, Placebo-Controlled Study of Metformin and Atorvastatin for the Treatment of Depression and Medical Comorbidity (ACTRN1262300061162
Hearts and Minds: A 3-arm Multicentre, Randomised, Double-Blind, Placebo-Controlled Study of Metformin and Atorvastatin for the Treatment of Depression and Medical Comorbidity (ACTRN1262300061162
/